European white paper: oropharyngeal dysphagia in head and neck cancer

Baijens L. W. J., Walshe M., Aaltonen L., Arens C., Cordier R., Cras P., ...More

European Archives of Oto-Rhino-Laryngology, vol.278, no.2, pp.577-616, 2021 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 278 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.1007/s00405-020-06507-5
  • Journal Name: European Archives of Oto-Rhino-Laryngology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.577-616
  • Keywords: Deglutition, Dysphagia, Head and neck cancer, Swallowing, White paper
  • Hacettepe University Affiliated: Yes

Abstract

Purpose: To develop a European White Paper document on oropharyngeal dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the management of OD associated with HNC across Europe. Methods: Experts in the management of specific aspects of OD in HNC across Europe were delegated by their professional medical and multidisciplinary societies to contribute to this document. Evidence is based on systematic reviews, consensus-based position statements, and expert opinion. Results: Twenty-four sections on HNC-specific OD topics. Conclusion: This European White Paper summarizes current best practice on management of OD in HNC, providing recommendations to support patients and health professionals. The body of literature and its level of evidence on diagnostics and treatment for OD in HNC remain poor. This is in the context of an expected increase in the prevalence of OD due to HNC in the near future. Contributing factors to increased prevalence include aging of our European population (including HNC patients) and an increase in human papillomavirus (HPV) related cancer, despite the introduction of HPV vaccination in various countries. We recommend timely implementation of OD screening in HNC patients while emphasizing the need for robust scientific research on the treatment of OD in HNC. Meanwhile, its management remains a challenge for European professional associations and policymakers.